A case series of morbid COPD exacerbations during immune checkpoint inhibitor therapy in cancer patients.

Nair, Viswam S; Eaton, Keith; McGarry Houghton, A

Nair, Viswam S; Eaton, Keith; McGarry Houghton, A.

Afiliación

Nair VS; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave, Seattle, WA, 98109, USA.
Eaton K; Division of Pulmonary, Critical Care & Sleep Medicine, University of Washington School of Medicine, 1959 NE Pacific St, Seattle, WA, 98195, USA.
McGarry Houghton A; Thoracic, Head & Neck Medical Oncology, Seattle Cancer Care Alliance, 1354 Aloha St, Seattle, WA, 98109, USA.

Respir Med Case Rep ; 34: 101541, 2021.

Article en En | MEDLINE | ID: mdl-34760616

Palabras clave

Adverse effects; COPD; Checkpoint inhibitors; Immunotherapy; Lung cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Guideline Idioma: En Revista: Respir Med Case Rep Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google